Oxford Biodynamics PLC Cash Flow Conversion Efficiency
Oxford Biodynamics PLC cash flow conversion efficiency. Based on the latest financial reports, Oxford Biodynamics PLC (OBD) has a cash flow conversion efficiency ratio of -1.388x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-4.51 Million ≈ $-549.10 USD) by net assets (GBX3.25 Million ≈ $395.67 USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Oxford Biodynamics PLC (2013–2025)
Cash flow conversion efficiency of Oxford Biodynamics PLC from 2013 to 2025. This chart illustrates how Oxford Biodynamics PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data. View OBD stock price and chart for real-time trading data and today's change.
Oxford Biodynamics PLC Cash Flow Conversion Ratio Explained
Oxford Biodynamics PLC cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Oxford Biodynamics PLC Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Oxford Biodynamics PLC ranked by their cash flow conversion efficiency. Also see market cap of Oxford Biodynamics PLC for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Northann Corp.
NYSE MKT:NCLX
|
-0.076x |
|
Cloudbreak Discovery PLC
LSE:CDL
|
1.916x |
|
Image Scan Holdings Plc
LSE:IGE
|
-0.246x |
|
Selina Hospitality PLC
NASDAQ:SLNAF
|
-0.016x |
|
22nd Century Group Inc
NASDAQ:XXII
|
0.174x |
|
Bangkok Bank Public Company Limited
F:BKKF
|
0.014x |
|
Sporttotal AG
F:WIG1
|
0.078x |
|
ECR Minerals plc
LSE:ECR
|
0.041x |
Annual Cash Flow Conversion Efficiency for Oxford Biodynamics PLC (2013–2025)
The table below shows the annual cash flow conversion efficiency of Oxford Biodynamics PLC from 2013 to 2025. Review Oxford Biodynamics PLC (OBD) FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | GBX1.12 Million ≈ $135.78 |
GBX-7.71 Million ≈ $-937.96 |
-6.908x | -195.95% |
| 2024-09-30 | GBX4.36 Million ≈ $530.24 |
GBX-10.17 Million ≈ $-1.24K |
-2.334x | -67.53% |
| 2023-09-30 | GBX6.05 Million ≈ $736.72 |
GBX-8.44 Million ≈ $-1.03K |
-1.393x | +30.35% |
| 2022-09-30 | GBX2.59 Million ≈ $314.88 |
GBX-5.18 Million ≈ $-629.89 |
-2.000x | -126.23% |
| 2021-09-30 | GBX6.69 Million ≈ $814.34 |
GBX-5.92 Million ≈ $-720.05 |
-0.884x | -253.08% |
| 2020-09-30 | GBX13.58 Million ≈ $1.65K |
GBX-3.40 Million ≈ $-413.80 |
-0.250x | -94.01% |
| 2019-09-30 | GBX17.59 Million ≈ $2.14K |
GBX-2.27 Million ≈ $-276.32 |
-0.129x | -33.26% |
| 2018-09-30 | GBX20.05 Million ≈ $2.44K |
GBX-1.94 Million ≈ $-236.29 |
-0.097x | +26.40% |
| 2017-09-30 | GBX11.60 Million ≈ $1.41K |
GBX-1.53 Million ≈ $-185.67 |
-0.132x | +24.40% |
| 2016-09-30 | GBX7.74 Million ≈ $942.10 |
GBX-1.35 Million ≈ $-164.01 |
-0.174x | -28.08% |
| 2015-09-30 | GBX9.04 Million ≈ $1.10K |
GBX-1.23 Million ≈ $-149.53 |
-0.136x | -67.82% |
| 2014-09-30 | GBX5.24 Million ≈ $636.95 |
GBX-424.00K ≈ $-51.59 |
-0.081x | -225.24% |
| 2013-09-30 | GBX2.94 Million ≈ $357.47 |
GBX190.00K ≈ $23.12 |
0.065x | -- |
About Oxford Biodynamics PLC
Oxford BioDynamics Plc, together with its subsidiaries, operates as a biotechnology company that y developing, and commercializing precision medicine tests for life-changing diseases in the United States and the United Kingdom. The company provides EpiSwitch CiRT (Checkpoint inhibitor Response Test), a blood test that predicts an individual patient's therapeutic response to checkpoint inhibitor i… Read more